NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | NT 10-K: Others
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | 10-Q: Q3 2021 Earnings Report
NUGENEREX IMMUNO-ONCOLOGY INC | DEFR14C: Others
NUGENEREX IMMUNO-ONCOLOGY INC | DEF 14C: Definitive information statements
NUGENEREX IMMUNO-ONCOLOGY INC | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
NUGENEREX IMMUNO-ONCOLOGY INC | PRE 14C: Preliminary information statement not related to a contested matter or merger/acquisition
NUGENEREX IMMUNO-ONCOLOGY INC | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | 10-Q: Q2 2021 Earnings Report
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K/A: Current report (Amendment)
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | 10-Q/A: Quarterly report (Amendment)
NUGENEREX IMMUNO-ONCOLOGY INC | 10-Q: Quarterly report
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
NUGENEREX IMMUNO-ONCOLOGY INC | 8-K: Current report
No Data